Fiduciary Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.62M Sell
1,400
-69
-5% -$81.4K 0.19% 76
2026
Q2
$1.76M Buy
1,469
+122
+9% +$125K 0.2% 69
2026
Q1
$1.24M Buy
1,347
+522
+63% +$529K 0.16% 89
2025
Q4
$886K Buy
825
+6
+0.7% +$5.74K 0.13% 112
2025
Q3
$625K Sell
819
-30
-4% -$22.3K 0.1% 130
2025
Q2
$659K Buy
849
+61
+8% +$47.4K 0.12% 115
2025
Q1
$568K Buy
788
+1
+0.1% +$832 0.12% 112
2024
Q4
$630K Buy
787
+371
+89% +$307K 0.14% 100
2024
Q3
$380K Sell
416
-7
-2% -$6.29K 0.09% 154
2024
Q2
$398K Buy
+423
New +$338K 0.1% 129

Other funds holding LLY

Fiduciary Financial Group's LLY Position: Q3 2026 in Review

Fiduciary Financial Group reduced its Eli Lilly (LLY) stake by 4.7% in Q3 2026, selling an estimated $81.4K and leaving 1,400 shares worth $1.62M. The position accounts for 0.19% of the portfolio, ranked #76.

Fiduciary Financial Group first reported a position in LLY in Q2 2024 and has held it in 10 quarters since. The position peaked at $1.76M in Q2 2026. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Fiduciary Financial Group held 1,400 shares of Eli Lilly worth $1.62M as of Q3 2026.
  • Fiduciary Financial Group sold 69 Eli Lilly shares in Q3 2026, an estimated $81.4K.
  • Eli Lilly made up 0.19% of Fiduciary Financial Group's portfolio in Q3 2026, its #76 holding.
  • Fiduciary Financial Group first reported a position in Eli Lilly in Q2 2024 and has held it in 10 quarters since.
  • Fiduciary Financial Group's Eli Lilly position peaked at $1.76M in Q2 2026.
  • 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Fiduciary Financial Group's 13F filing for Q3 2026, filed 13 Oct 2026.